Form
Approved
OMB No. 0935-XXXX
Exp. Date XX/XX/20XX
AHRQ MRSA Prevention
Gap Analysis – Surgical Services
Organization Name: |
|
|
|
Date Completed: |
|
|
|
Surgical Service Name: |
|
Type of Surgical Service:
Purpose: |
To evaluate existing resources and processes and identify areas of improvement to facilitate interventions to reduce the incidence and prevalence of surgical site infections caused by methicillin-resistant Staphylococcus aureus (MRSA), the primary goal of participation in the AHRQ Safety Program for MRSA Prevention. |
Outcome: |
This gap analysis will be completed twice, once at the beginning and once at the end of participation in the AHRQ Safety Program. When completed at the start of the Safety Program, it will be used by the project team to understand needs of participating hospitals and by participating hospitals to prioritize areas for improvement and advocate for institution-level and service-level resources. When completed at the end of the Safety Program, both the project team and the participating hospitals will use the gap analysis to assess progress in building infrastructure and capacity to sustainably reduce MRSA infections. |
Instructions: |
Public
reporting burden for the collection of information is estimated
to average 1 hour per response. An agency may not conduct or
sponsor, and a person is not required to respond to, a collection
of information unless it displays a currently valid OMB control
number. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions
for reducing this burden, to: AHRQ Reports Clearance Officer,
Attention: PRA, Paperwork Reduction Project (0935-0143), AHRQ,
5600 Fishers Lane, MS 0741A, Rockville, MD 20857. The
confidentiality of your responses is protected by Sections 944(c)
and 308(d) of the Public Health Service Act [42 U.S.C. 299c-3(c)
and 42 U.S.C. 242m(d)]. Information that could identify you will
not be disclosed unless you have consented to that disclosure. |
Item Description |
Response |
INFECTION PREVENTION PROGRAM STRUCTURE AND RESOURCES |
|
Staffing |
|
Number of infection preventionists (ICP) fulltime equivalents (FTEs) for the hospital |
|
Is there a hospital epidemiologist? |
|
If yes, how much time does the hospital epidemiologist dedicate to the infection prevention program (% effort of hours/week or FTEs) |
|
Is the hospital epidemiologist available to the infection prevention program on a daily basis? |
|
Senior Leadership |
|
To whom does the infection prevention program report (provide position title and department, not a specific name)? |
|
How often does infection prevention leadership meet with senior leadership? |
|
Does senior leadership actively promote/support infection prevention activities (check all that apply)?
|
|
Data Analysis and Management |
|
Is a data analyst available to assist with obtaining, managing, analyzing, and reporting infection prevention data? |
|
Is access to the data analyst support adequate to meet program goals? |
Yes / No |
Select existing method of storing infection data. (check all that apply)
|
|
For which of the following surgical procedures is data submitted to CDC/NHSN (check all that apply)? |
|
Microbiology |
|
Is there a microbiology laboratory on site? |
Yes / No |
Does the infection prevention team have access to microbiology results as soon as those results are finalized? |
Yes / No |
Does your lab have the capacity to process surveillance cultures either on-site or by sending samples to a reference laboratory? |
Yes / No |
Does your lab have access to a rapid test to detect S. aureus nasal colonization, either on-site or by sending samples to a reference laboratory? |
Yes / No |
Interactions with Services |
|
Is an infection preventionist assigned to each surgical service? |
|
If an infection preventionist is assigned to all or some surgical services, does the infection preventionist participate in their surgical service’s patient safety/quality improvement meetings? |
|
Surgical Site Infection Surveillance |
|
Surgical Site Infections (SSI) |
|
Please indicate which procedure(s) will be the focus of your facility’s participation in the AHRQ MRSA Prevention Program? (check all that apply)
*The electronic version will supply branching logic for items below so that only relevant questions will be asked based on the response to this question. |
|
Is surveillance performed for SSIs associated with hip replacement? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with hip replacement, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with knee replacement? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with knee replacement, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with spinal fusion? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with spinal fusion, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with laminectomy? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with laminectomy, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with craniotomy? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with craniotomy, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with coronary artery bypass grafting (CABG)? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with coronary artery bypass grafting (CABG), do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
Is surveillance performed for SSIs associated with cardiac valve replacement? |
Yes / No |
If yes, with what frequency? |
|
If yes, how are SSI cases detected (select all that apply)? |
|
If yes, are the SSI data fed back to the surgical service? |
Yes / No |
If yes to providing SSI data feedback to the surgical service, indicate the frequency of data feedback to the surgical service. |
|
If yes to performing SSI surveillance associated with cardiac valve replacement, do you have a process to validate the SSI data? |
Yes / No |
If yes to validating SSI data, how is the surveillance data validated (choose all that apply)? |
|
PART 2: Service Level Infection Prevention Activities
Please indicate which of the following strategies are implemented for patients undergoing the procedure that is being evaluated in the Safety Program. If your site has more than one service participating, Part 2 should be completed for each service separately.
Item |
Response |
Please indicate the procedure for which you are completing this section. If your facility has more than one surgical service participating in the AHRQ MRSA Safety Program or if a participating service performs more than one listed procedure, please complete this section for each procedure that will be a focus of your facility’s participating. |
|
Is preoperative S. aureus surveillance performed by cultures, polymerase chain reaction (PCR) or other testing methodology? |
|
If yes, are results available in time to guide decision-making about antibiotic prophylaxis? |
|
If yes, is there a system in place to monitor compliance with the preoperative testing? |
|
If yes, how often is feedback about preoperative testing compliance provided to the service? |
|
Is chlorhexidine (CHG) treatment (bathing) recommended to patients prior to the surgical procedure? |
|
If yes, how is the CHG treatment provided to patients? |
|
If yes, is the patient provided instructions for how to apply CHG? |
|
If yes, what is the CHG treatment regimen that is recommended? (select all that apply) |
|
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Is intranasal Mupirocin or iodophor decolonization performed prior to the surgical procedure? |
|
If yes, how is the Mupirocin or iodophor treatment provided to patients? |
|
If yes, is the patient provided instructions for how to apply Mupirocin or iodophor? |
|
If yes, what is the intranasal Mupirocin or iodophor regimen that is recommended? (select all that apply) |
|
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Is there a formal protocol for skin antiseptic preparation prior to incision? |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Is there a protocol for the location where hair is removed from the patient before the surgical procedure? |
|
Is there a protocol to ensure proper surgical hand scrub for staff before the surgical procedure? |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Is there a protocol for proper surgical attire for staf?f |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have training programs for staff in the following areas (check all that apply): |
|
Does the facility have guidelines for selection of peri-procedure antibiotics? |
Yes / No |
Does the facility have recommendations for dosing peri-procedure antibiotics according to weight? |
Yes / No |
Does the facility have a protocol for the addition of vancomycin to pre-procedure antibiotic prophylaxis for patients with MRSA? |
Yes / No |
Does the facility have a protocol in place to ensure pre-procedure antibiotics are administered at the appropriate time prior to incision? |
Yes / No |
If yes, is there a system in place to monitor compliance? (select all that apply) |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have a protocol in place to ensure re-dosing of antibiotics during the procedure when indicated? |
Yes / No |
If yes, is there a system in place to monitor compliance? (select all that apply) |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have a protocol in place to ensure peri-operative antibiotic prophylaxis is stopped within 24 hours (or 48 hours for cardiac surgery)? |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have a protocol in place to ensure optimal glycemic control in the peri-operative period? |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have a protocol in place to ensure proper patient warming in the operating room? |
Yes / No |
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
Does the facility have a protocol for implementation of the central line associated bloodstream infection (CLABSI) prevention insertion bundle in the OR? |
Yes / No |
If yes, indicate which of the following elements are included: (select all that apply) |
|
If yes, is there a system in place to monitor compliance? |
|
If yes, how often is feedback about compliance provided to the service? |
|
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Samuel Kim |
| File Modified | 0000-00-00 |
| File Created | 2021-07-27 |